Outperforming pretty much every other contender for the title of chief apologist for the Zionist state of Israel is Europe’s ...

When facing complex global challenges, ethical leadership plays a crucial role in determining whether companies prioritise ...

Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to ...

Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.

However, the post-COVID turnaround under CEO Albert Bourla isn't happening fast enough for some. Pfizer jumped into the headlines recently after activist investor Starboard Value acquired a $1 billion ...

Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...

W hat a twist! An activist investment fund, Starboard Value, has recently been pushing Pfizer (NYSE: PFE) to increase ...

Selling the news is a common trading strategy in which traders buy a stock in anticipation of expected news, then sell once ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...